OX2 Therapeutics, Inc.
New Filing
CIK: 0001704490·Biotechnology·DELAWARE·Filed: Sep 22, 2020
Total Offering
$750,007
Amount Sold
$649,415
Investors
15
First Sale
Aug 20, 2020
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2016
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jeff Liter | Related Person |
| Mike Olin | Related Person |
| Christopher Moertel | Related Person |
| Rob Parish | Related Person |
| Andrea Hunt | Related Person |
| Ben Oehler | Related Person |
Company
SEC Filing
0001437749-20-019981
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free